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cardiovascular non-stent PMAs approved during that time with a study with at least
one primary endpoint, 16 (24%) had a study modification or primary endpoint
reinterpretation. In one stent PMA, a study did not meet at least one pre-specified
primary endpoint, but the device was approved on the basis of a post-hoc data review.
In another stent PMA, pre-specified statistical analyses were changed after study
initiation.
Conclusion: The most rigorous FDA review process for devices includes numerous
forms of study modifications and primary endpoint reinterpretations, but these occur
less frequently for coronary and non-coronary stent studies. As these types of analyses
reduce confidence in conclusions, more consistent requirements for pre-specified
clinical trial outcomes will help improve the quality and consistency of the approval
process.
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Background: Coronary artery disease (CAD) is the most common cause for left
ventricular dysfunction (LVD). Coronary artery bypass surgery (CABG) results in
equivalent benefit in reducing mortality compared with medical therapy in patients
with CAD and severe LVD. However, the benefit of percutaneous coronary
intervention (PCI) in patients with severe LVD is not clear. A meta-analysis of studies
utilising PCI in patients with severe LVD (EF≤40%) was performed to determine in-
hospital (IH) and long-term (LT) [≥1year] mortality.
Methods: A systematic computerised literature search was performed. Studies of
patients undergoing PCI for CAD in the presence of severe LVD were included. Studies
that did not report LT mortality and same centre studies were excluded.
Results: In total, 4766 patients (19 studies) were included. The mean (pooled estimate)
age was 64.7 years with a mean (estimate) EF of 29.9% and 79.7% were men. The IH
mortality rate using random effects model (13 studies, total PCI n=2202, 39 deaths)
was 1.8% (95% CI 1.0-2.9%). The LT mortality rate (23.86 months) using random
effects model (19 studies, total follow-up n=2937, 401 deaths) was 15.6% (95% CI
11.0-20.7%). Five studies compared PCI versus CABG (n=455 vs. n=502) and provide
LT mortality data (PCI n=102 vs. CABG n=115 deaths). The relative risk using random
effects model (PCI vs. CABG) was 0.98 (95% CI 0.78-1.22, p value 0.83).
Long-term Mortality Following PCI in Severe LV Dysfunction: A Meta-analysis
Conclusion: This meta-analysis demonstrates that based on available clinical studies,
PCI among patients with severe LVD is feasible with acceptable in-hospital and long-
term mortality and yields comparable outcomes with CABG.
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Background: Late catch-up phenomenon in target lesion revascularization (TLR) is
one of the problems after sirolimus-eluting stent (SES) implantation. However, the
way to reduce late TLR after SES implantation has not been established.
Methods: Among 13087 patients undergoing first percutaneous coronary intervention
in the CREDO-Kyoto registry Cohort-2 from January 2005 to December 2007, 10221
patients were implanted only SES (SES stratum: 5029) or only bare-metal stent (BMS)
(BMS stratum: 5192). To evaluate the impact of statin therapy on late TLR (1-year to
4-year), SES implanted patients were divided into 2 groups according to the statin
therapy at discharge (statin group: 2735, non-statin group: 2294). BMS implanted
patients were also divided into 2576 statin and 2616 non-statin group.
Results: Incidence of late TLR was significantly higher in SES implanted patients
compared to BMS implanted patients (7.7% vs. 3.0%, P<0.0001). In SES stratum,
incidence of late TLR was significantly lower in the statin group than in the non-statin
group (6.1% vs. 9.6%, P=0.002), although no significant difference was found in BMS
stratum (2.6% vs. 3.3%, P=0.38). After adjusting confounders, the risk for late TLR
was significantly lower in the statin group in SES stratum (hazard ratio (HR) 0.66 [95%
confidence interval (CI) 0.50-0.88], P=0.004), although the risk was comparable in
BMS stratum (HR 0.83 [95% CI 0.52-1.31], P=0.42).
Conclusion: Incidence of late TLR was significantly higher in SES than in BMS
implanted patients. Statin therapy significantly reduced late TRL after SES
implantation, although significant risk reduction was not found after BMS
implantation.
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Background: Socioeconomic factors such as insurance and household income impact
cardiovascular risk and outcomes, but the influence of marital status upon outcomes
following PCI is poorly understood.
Methods: We compared 2971 currently married patients to 2213 unmarried patients,
defined as single, widowed, divorced or separated, at one year following PCI. Patients
were followed for 1 year in regards to the combined endpoint of all-cause death and
MI; the latter was defined as CK-MB elevation ≥2 times upper limit of normal and/or
new Q waves or ST elevation ≥1 mm. Multivariable Cox proportional hazards
regression was performed to adjust for confounders.
Results: Married patients, compared to unmarried patients, were more likely to be
male (76.3% v. 53.6%) or Caucasian (77.0% v. 59.4%) and were less likely to present
with acute coronary syndrome (10.1% v. 16.5%) or have congestive heart failure
(11.1% v. 15.8%) or chronic renal insufficiency (8.8% vs. 14.2%; p<0.001 for all
comparisons). Unadjusted 1-year death (3.2% v. 7.4%, p<0.001) and death plus MI
(4.3% v. 9.6%, p<0.001) were lower among married patients compared to married
patients, as was definite and probable stent thrombosis (0.4% v. 1.2%, p=0.002).
Following multivariable adjustment, being married remained associated with lower
rates of death and MI at 1 year (HR 1.63, 95% CI 1.29-2.07, p<0.001; Table).
Conclusion: The presence of social support, possibly by ensuring better medication
compliance, lifestyle modification and follow-up, improves outcomes following PCI.
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Background: Pressure-controlled intermittent coronary sinus occlusion (PICSO®)
may serve as an adjuvant therapy in acute myocardial infarction by augmenting
redistribution of blood to the border zone of the ischemic myocardium. This first-in-
man study evaluated safety and feasibility of PICSO®, and its effect on coronary
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hemodynamics during elective PCI.
Methods: A total of 15 patients with stable angina were included. The coronary sinus
(CS) catheter was introduced by the right femoral vein route. Left anterior descending
artery (LAD) distal pressure was continuously measured using a sensor-equipped guide
wire. Balloon occlusion of the LAD was performed twice, lasting maximally 3 minutes
each, to document the effect of PICSO® on CS pressure (CSP) and distal LAD wedge
pressure. An occlusion was performed once with PICSO® and once without PICSO®.
Results: Catheter delivery was successful in all patients (mean duration 12.7±6.5
minutes). The study protocol could not be completed in 5 out of 15 patients due to
initial calibration problems (n=3), a pressure wire problem (n=1) and a vagal response
(n=1). In the other 10 study patients, the procedure was uncomplicated and no device-
related events occurred during 54±29 days follow up. During LAD occlusion, CS
occlusion caused a marked increase in mean CSP (4.1±7.3 mmHg vs. 22.0±12.6
mmHg; P<0.001) and CS pulse pressure (4.3±0.8 mmHg vs. 36.1±6.3 mmHg;
P<0.001). Concomitantly, mean distal LAD wedge pressure (32.4±12.2 mmHg vs.
35.5±12.6 mmHg; P<0.001) and distal LAD wedge pulse pressure (39.1±27.2 mmHg
vs. 45.9±26.0 mmHg; P<0.001) increased (figure).
Conclusion: PICSO® is safe and feasible in the cardiac catheterization laboratory
using femoral vein access. PICSO® augments CSP leading to an increase in coronary
wedge pressure.
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Background: Only a few studies presented concerning anemia because of its
association with myocardial ischemia, and demonstrated that anemia is an independent
predictor of high 30-day major adverse cardiac and cerebrovascular events (MACCEs)
and 1-year MACEs after percutaneous coronary intervention (PCI).
Methods: Anemia was defined by WHO criteria (hemoglobin below 12 g/dL for
female and below 13 g/dL for male subjects). Laboratory study was performed at the
index drug-eluting stent (DES) implantation and at the outpatient visit between 3moths
and 12months later. We categorized patients into four groups based on initial and
follow-up hemoglobin levels (normal, anemia-corrected, newly developed anemia,
sustained anemia groups).
Results: We analyzed consecutive 9292 patients performed PCI with DESs from
January, 2004 to December, 2009. Of these, 4300 subjects with initial and follow-up
hemoglobin were enrolled and median follow up period was 25.6 months. After
adjusting multiple covariates, sustained anemia group demonstrated a significant
increase in a hazard ratio (HR) of a composite of death, myocardial infarction, and
stroke (HR=2.745, p<0.001, 95% confidence interval (CI) 2.030 to 3.712) comparing
with normal group. There was also significant increase of HR in the corrected anemia
group (p<0.001, 95% CI 1.359 to 2.539) but this group shows better clinical outcome
than sustained anemia group.
Kaplan-Meier curve of cumulative free from MACCE rate for patients who
underwent DES, according to anemia group.
Conclusion: Follow up of hemoglobin is important and the correction of anemia during
follow up periods can improve patients’ clinical outcomes. The effort to establish
treatment options for anemia and to detect and treat underlying medical problems
should be asserted.
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Background: The optimal threshold for predicting mortality with troponin I, in
particular in patients with renal dysfunction, remains poorly defined.
Methods: Consecutive patients were included if they were evaluated and discharged
from the emergency department (ED) at any of the 11 participating centers between
January 2006 and December 2009. Participants were required to have at least 2 serial
troponin I values in the ED. All troponin I values were obtained using the same assay.
The study sample was randomly divided into a derivation and validation cohort. The
derivation data set was used to calculate a troponin I threshold for a 30 day all-cause
mortality. Bootstrap estimates, sampling with replacement, yielded the average best
cut off and 95% CI. Performance of the threshold was then evaluated in a validation
cohort.
Results: There were 71,666 patients in the study cohort. The bootstrap estimate of the
cut off value of troponin I in the derivation cohort was 0.06 (95% CI: 0.05 – 0.07).
Predicted mortality by estimated GFR and troponin I values in the derivation and
validation cohorts are shown in the figures.
Conclusion: In this cohort, very minor troponin I elevations were predictive of 30-
day mortality after presentation to the ED for all levels of renal function.
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Regular exercise improve FMD, carotid IMT, and EPC in PCI patients
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Background: As exercise improves endothelial dysfunction, we investigated the effect
of training on angiogenesis by measuring the number of circulating endothelial
progenitor cells (EPCs), and tested vascular function by flow-mediated dilation (FMD)
and carotid intima-media thickness (IMT) in patients with percutaneous coronary
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